Baidu
map

90后女演员患淋巴瘤去世,淋巴瘤这些知识你不可不知

2016-09-08 MedSci MedSci原创

又一个年轻的生命被病魔夺走。9月7日下午,90后新生代女演员徐婷因罹患淋巴癌,医治无效离世。她的最后一条微博停留在8月18日“……感觉快窒息了,真的太痛苦太痛苦了!”日本著名男演员高仓健因淋巴癌去世引发关注。此前,日本著名男演员高仓健,原央视新闻联播主持人罗京、琼瑶女郎李钰、台湾歌手阿桑等明星,去年大热的电影《滚蛋吧!肿瘤君》的漫画版作者熊顿、2014年被称为成都最帅交警的秦思瀚等网络名人都是因淋

又一个年轻的生命被病魔夺走。

9月7日下午,90后新生代女演员徐婷因罹患淋巴瘤,医治无效离世。

她的最后一条微博停留在8月18日

“……感觉快窒息了,真的太痛苦太痛苦了!”



此前,日本著名男演员高仓健,原央视新闻联播主持人罗京、琼瑶女郎李钰、台湾歌手阿桑等明星,去年大热的电影《滚蛋吧!肿瘤君》的漫画版作者熊顿等都是因淋巴瘤逝世。

那么究竟什么是淋巴瘤?该如何预防和治疗?





淋巴瘤是起源于淋巴系统并常播散到全身各处的恶性肿瘤,其在恶性肿瘤里发病率排第7位。淋巴瘤分为非霍奇金淋巴瘤(NHL)和霍奇金淋巴瘤(HL)两大类,约80%被确诊的淋巴瘤是非霍奇金淋巴瘤。近年来非霍奇金淋巴瘤的发病率上升较快,是我国十大恶性肿瘤之一。其可发于各个年龄段,男性发病率高于女性,儿童患者中非霍奇金淋巴瘤更常见。

众所周知,淋巴细胞几乎遍布全身,如淋巴结、皮肤、扁桃体、骨髓、脾脏、胃肠道等,只要有血液、淋巴液通过的地方就有淋巴细胞,而有淋巴细胞的部位就有发生淋巴瘤的可能性,淋巴瘤细胞可以随着淋巴系统在全身游走,部分可以侵犯人体血液。因此,与乳腺癌结直肠癌等恶性肿瘤相比,一旦发现某个部位有淋巴瘤,基本上其他部位也有,而且淋巴瘤并不能通过手术切除治疗。

淋巴瘤的发病因素与预防:

目前,淋巴瘤的具体发病原因在医疗圈还没有明确的定论,但普遍被认为可能与感染因素、环境因素、异常免疫调节、遗传等因素有关。

1.感染:暴露于HTLV、HIV、EBV、HCV,感染幽门螺杆菌等;
2.环境:身心压力较大,作息不良,长期暴露于化学有害物质及放射环境等;
3.异常免疫调节:有自身免疫性疾病,接受过化疗或放疗,患乳糜泻,服用抑制免疫力的药物等;
4.遗传:有相关家族病史的群体的 NHL 发病风险可能会增加 2-4 倍。因此这类人群最好定期到医院筛查淋巴瘤。

淋巴瘤预防的关键是免疫力,因此人们可以通过矫正不良生活习惯、适度增加锻炼来提高免疫力;同时,要尽量避免感染、避免接触射线和其它有害化学物质;对于有相关疾病家族史的人群,最好定期到医院做胸腹部 CT;淋巴瘤高风险人群,务必做到早发现早治疗;发现淋巴结肿大者,尽早就医。

淋巴瘤的发病特征:

70%的淋巴瘤发生在淋巴结,比如颈部、腋下、腹股沟等,如果是颈部、腋下等浅表部位,可以通过体格检查时摸到无痛感的淋巴结肿块发现,但发生在深部组织时就只能通过检查发现了;还有30%的淋巴瘤是发生在淋巴结外的,脑、咽喉、肺部、女性乳房、男性睾丸等,这种类型的淋巴瘤会在其发病部位表现出相应的症状,比如长在鼻子就会流鼻血,长在胃部就会胃疼等。

临床上依据无痛性进行性淋巴结肿大和(或)结外器官组织受累,伴或不伴发热、盗汗、消瘦等临床表现,及淋巴结或受累器官组织的活组织病理检查结果对淋巴瘤进行确诊。

淋巴瘤的分期:

临床上常用的分期依然是Ann Arbor分期,但在NHL患者中该分期与临床预后的相关性不如霍奇金淋巴瘤,而且NHL是一系统性疾病,其发病部位常呈“跳跃式",所以目前更主张以国际预后指数(IPI)和滤泡淋巴瘤国际预后指数(FLIPI)来判断NHL患者的疾病程度。

淋巴瘤的治疗:

因淋巴瘤为全身性疾病,所以治疗上多数患者应以联合化疗为主。主要有以下几种治疗方法:

1.化学治疗:主要包括CHOP、利妥昔单抗、克拉曲滨等联合应用,依据不同的疾病类型和分期,及患者的身体状况给予不同的化疗方案;

2.免疫治疗:近些年发展较迅速的治疗手段,包括干扰素、各种细胞因子、各种单克隆抗体等;目前在临床应用上,除患者一般情况差、无法耐受化疗或疾病缓解后的利妥昔单抗维持治疗外,一般主张与化疗联合应用;

3.造血干细胞移植:主要针对常规治疗失败或缓解后复发的患者,在小部分患者中,甚至可考虑行异基因造血干细胞移植;

4.放疗:化疗的补充手段,多用于大瘤块部位化疗后的辅助治疗,以及一些残留病变的辅助治疗;

5.手术:更多是为明确诊断切除病变。

淋巴瘤的预后:

中山大学孙逸仙纪念医院肿瘤科化疗专科主任姚和瑞教授在今年早期的一次采访中曾介绍说:“淋巴瘤的预后与肿瘤的病理组织类型和临床分期以及是否采取合适的治疗手段密切相关,其中早期霍奇金淋巴瘤采用化疗、放疗等综合治疗,目前治愈率高达90%以上也有研究指出,NHL的总体10年相对生存率是59%,总体5年相对生存率是69%。

另外,对于淋巴瘤患者的化疗治疗,不能因为暂时的好转就停药,暂时的好转很容易复发,复发后再次化疗的过程会导致肿瘤细胞耐药,会增加治疗难度。

最后,对于淋巴瘤患者来说,患者本人的心态对预后也有部分影响。创新工场CEO李开复于2013年被确诊淋巴瘤,但他在治疗过程中一直呈现一种积极乐观的心态,最终,经过近2年的治疗,2015年李开复通过微博透露了他已康复。

对比李开复,下面是徐婷在治疗期间的一篇微博博文:




徐婷的博文中提到她因亲眼看到秦思瀚接受了生不如死的化疗治疗后依然去世,所以不愿意接受治疗,然而,她没有看到秦思瀚当年宣称放弃化疗时,其他淋巴瘤患者对他的鼓励:

网友一:坚持下去吧,我初二那年我妈也被查出白血病,坚持吃了这么多年格列卫,现在我大四了,我妈身体很好,工作生活都没问题,医生说病情稳定已经可以停药了。

网友二:我都化疗五年了,每年六个月以上的化疗,坚持治疗吧。不为别的,因为下狠心离开人世间太难了。相信生命不会那么脆弱!我白细胞100以下都达到过,昏睡一周不能吃喝,但是我还在化疗。没别的,只想鼓励你一下,还有比你命运更惨的人都不放弃,你要坚强!

......

人类目前四千种常见病,90%没有好药可治,最常见的感冒也不是药物治好的。人类七千种罕见病,99%以上没药可治。那我们生病了就不看病了,不吃药了吗?

医学是一门不确定的医学,我们不能因为一例个案而否定了医学的进步。逝者已矣,但是梅斯医学小编呼吁各位肿瘤患者们不要悲观、失望,保持积极乐观的心态,接受正规的肿瘤治疗,请相信医学,相信你自己!

死,只是一个结果,怎么活着,才是最重要的。

最后的最后,容梅斯医学小编向您推荐几个故事,希望看完这些故事,您能更认清生命与生存:




(这样的故事还有许多,更多内容尽在梅斯医学APP

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-10-11 右脚梅西

    很好,谢谢,很有帮助。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 医路开来

    啥时候能突破治疗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 医路开来

    疾病不能治疗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 1e0bc67dm33(暂无匿称)

    详细

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 知难而进

    谢谢分享!!!!!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 知难而进

    继续关注!!!!!!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 空心萝卜

    科技在进步,会一步一步解决病魔

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-09 刘煜

    天妒英才,惋惜。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=145322, encodeId=e13d145322a1, content=很好,谢谢,很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160930/IMG57EDFF4739EBF3035.jpg, createdBy=0da11618734, createdName=右脚梅西, createdTime=Tue Oct 11 20:14:25 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625592, encodeId=1e7216255920a, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Sat Sep 10 08:15:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114976, encodeId=01491149e619, content=啥时候能突破治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:47:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114975, encodeId=1dc91149e59e, content=疾病不能治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Fri Sep 09 10:46:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114880, encodeId=1bd211488048, content=详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Fri Sep 09 08:59:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114871, encodeId=792a1148e145, content=谢谢分享!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114872, encodeId=9da91148e256, content=继续关注!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Sep 09 08:08:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114859, encodeId=c740114859d7, content=科技在进步,会一步一步解决病魔, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160909/IMG57D228CFA5D2E1163.jpg, createdBy=26421948395, createdName=空心萝卜, createdTime=Fri Sep 09 07:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114842, encodeId=e78c1148428f, content=天妒英才,惋惜。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Fri Sep 09 06:54:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114675, encodeId=e13a1146e5ed, content=心理负担太大对疾病的恢复没有好处,所以要保持良好的心态, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 08 22:53:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 舒心和人

    心理负担太大对疾病的恢复没有好处,所以要保持良好的心态

    0

相关资讯

JCO:无证据表明GnRHa对淋巴瘤化疗后卵巢功能保护和生育有益(长期随机试验)

先前我们报道了在随访1年后,促性腺激素释放激素激动剂(GnRHa)不能预防淋巴瘤患者化疗导致的卵巢早衰(POF) ,但也许能提供卵巢储备功能的保护。现在,我们报告了随访5年后的最终结果分析。共有129例淋巴瘤患者在化疗期间随机分配到曲普瑞林+炔诺酮(GnRHa 组)或炔诺酮单药组(对照组)。在随访的第2、3、4、5、7年报告卵巢功能和生育情况。主要终点是POF,定义为在随访2年后至少有一次卵泡刺激

6个适应症!FDA批准艾伯维突破性药物Imbruvica治疗小淋巴细胞性淋巴瘤(SLL)

美国制药巨头艾伯维(AbbVie)近日宣布,美国食品和药物管理局(FDA)已更新突破性抗癌药Imbruvica(ibrutinib)的处方信息(Prescribing Information,PI),纳入2项III期临床研究的新数据,这些研究支持了Imbruvica扩大应用于慢性淋巴细胞白血病(CLL)和小淋巴细胞性淋巴瘤(SLL)的治疗。 此次标签更新纳入了Imbruvica一线治疗CLL

中医治疗癌症靠谱么?女演员徐婷患淋巴瘤去世带来的遗憾

n: 0px; padding: 0px; max-width: 100%; box-sizing: border-box !important; word-wrap: break-word !important;">而对于徐婷来说这样的痛苦都能坚持几个月为什么就不能接受现代医学的化疗那徐婷的妹妹徐丹丹后来也潘然悔悟后悔没有早点接受西医的治疗所以说癌症治疗不在于要花多少钱要多少高大上的神奇疗法而是

Oncogene:C-rel抑制B淋巴瘤生长机制

NF-KB信号通路能够参与调节癌症细胞生物学的多个方面,因此它被认为是促进肿瘤的重要通路之一。然而,NF-KB是由多个亚基构成的,对于其中的各个亚基在肿瘤发生过程中起着怎样的作用目前仍不清楚。 哺乳动物细胞内的NF-KB由五个亚基组成,包括:RelA/p65, RelB, c-Rel, p50/p105 (NF-κB1) 以及 p52/p100 (NF-κB2)。RelA 与 c-Rel参与

JCO:半相合造血干细胞移植可降低淋巴瘤患者的慢性GVHD风险

根据一项回顾性研究结果,淋巴瘤患者是否接受半组合相关捐赠或匹配同胞供体的造血干细胞移植,其生存具有可比性。不过使用半组合匹配的捐献者提供的干细胞患者,其慢性移植物抗宿主病(GVHD)风险明显降低。北卡罗莱纳州医疗系统淋巴瘤的癌症研究所的Nilanjan Ghosh博士和同事对987例降低强度预处理方案后进行半组合(n = 180)或HLA匹配(n = 807)的异基因造血干细胞移植(HSCT)患者

Lancet:双手腕自发性骨折-案例报道

患者男,72岁,因左手腕自发性骨折就诊。查体:患者的右手腕也有骨折。无淋巴结肿大。X片:骨折的尺骨远端广泛的溶骨性病变(如下图)。患者否认体重减轻、盗汗、前列腺问题等。PET:胸腹部未见原发性肿瘤,也没有发现其他骨骼病变,前列腺癌也不考虑。左尺骨活检:弥漫性大B细胞淋巴瘤。骨髓涂片和活检:未见恶性细胞。诊断:原发性骨质弥漫性大B细胞淋巴瘤 IIE期。治疗:3个周期的R-CHOP方案(利妥昔单抗治疗

Baidu
map
Baidu
map
Baidu
map